The emerging role of TRIB3 as a gene affecting human insulin resistance and related clinical outcomes Sabrina PrudenteEleonora MoriniVincenzo Trischitta Review Article 13 January 2009 Pages: 79 - 84
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities Eugenia ResminiFrancesco MinutoDiego Ferone Review Article 26 March 2009 Pages: 85 - 95
Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease Melania MancoUgo GiordanoValerio Nobili Original Article 07 October 2008 Pages: 97 - 104
Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus Boglárka LaczyJudit CsehIstván Wittmann Original Article 07 October 2008 Pages: 105 - 111
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease A. NarO. Gedik Original Article 07 October 2008 Pages: 113 - 118
Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats Liping ZhangYaping LiuHaiqin Rong Original Article 09 October 2008 Pages: 119 - 126
Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients Chen-Chung FuDu-An WuChin-Hsiao Tseng Original Article 14 October 2008 Pages: 127 - 134
Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes? Sandra Fernanda NunesIsabel Vitoria FigueiredoMaria Margarida Caramona Original Article 14 October 2008 Pages: 135 - 140
Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels Masafumi KogaHiroshi SaitoSoji Kasayama Original Article 07 October 2008 Pages: 141 - 144
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis Kevin M. PantaloneMichael W. KattanRobert S. Zimmerman Original Article 05 February 2009 Pages: 145 - 154
Pantalone et al.: The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis David S. H. Bell Letter to the Editor 20 March 2009 Pages: 155 - 155
Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis” Robert S. ZimmermanKevin Matthew Pantalone Letter to the Editor 22 March 2009 Pages: 157 - 157
Cardiometabolic risk and educational level in adult patients with type 1 diabetes J. NádasZ. PutzG. Jermendy Short Communication 09 October 2008 Pages: 159 - 162
